496 related articles for article (PubMed ID: 31473342)
1. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
2. Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.
Baker LE; Ellena JF; Handing KB; Derewenda U; Utepbergenov D; Engel DA; Derewenda ZS
Acta Crystallogr D Struct Biol; 2016 Jan; 72(Pt 1):49-58. PubMed ID: 26894534
[TBL] [Abstract][Full Text] [Related]
3. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
[TBL] [Abstract][Full Text] [Related]
8. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
[TBL] [Abstract][Full Text] [Related]
9. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.
Kuhn JH; Becker S; Ebihara H; Geisbert TW; Johnson KM; Kawaoka Y; Lipkin WI; Negredo AI; Netesov SV; Nichol ST; Palacios G; Peters CJ; Tenorio A; Volchkov VE; Jahrling PB
Arch Virol; 2010 Dec; 155(12):2083-103. PubMed ID: 21046175
[TBL] [Abstract][Full Text] [Related]
11. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
[TBL] [Abstract][Full Text] [Related]
12. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
13. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.
Shu Q; Kenny T; Fan J; Lyon CJ; Cazares LH; Hu TY
PLoS Pathog; 2021 Nov; 17(11):e1010039. PubMed ID: 34748613
[TBL] [Abstract][Full Text] [Related]
14. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
15. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
16. Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
Warfield KL; Dye JM; Wells JB; Unfer RC; Holtsberg FW; Shulenin S; Vu H; Swenson DL; Bavari S; Aman MJ
PLoS One; 2015; 10(3):e0118881. PubMed ID: 25793502
[TBL] [Abstract][Full Text] [Related]
17. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
[TBL] [Abstract][Full Text] [Related]
18. STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV).
Escaffre O; Juelich TL; Neef N; Massey S; Smith J; Brasel T; Smith JK; Kalveram B; Zhang L; Perez D; Ikegami T; Freiberg AN; Comer JE
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372594
[TBL] [Abstract][Full Text] [Related]
19. Drug targets in infections with Ebola and Marburg viruses.
Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
[TBL] [Abstract][Full Text] [Related]
20. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis.
Tambunan USF; Alkaff AH; Nasution MAF; Parikesit AA; Kerami D
J Mol Graph Model; 2017 Jun; 74():366-378. PubMed ID: 28482272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]